Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.

about

Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.

Item

http://www.wikidata.org/entity/Q36176854

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Acquired latent tuberculosis i ...... he People's Republic of China.

@ast

Acquired latent tuberculosis i ...... he People's Republic of China.

@en

type

Item

label

Acquired latent tuberculosis i ...... he People's Republic of China.

@ast

Acquired latent tuberculosis i ...... he People's Republic of China.

@en

prefLabel

Acquired latent tuberculosis i ...... he People's Republic of China.

@ast

Acquired latent tuberculosis i ...... he People's Republic of China.

@en

P1476

Acquired latent tuberculosis i ...... the People's Republic of China

@en

P2093

Hong Jia

http://www.w3.org/2001/XMLSchema#string

Juan-Qin Gong

http://www.w3.org/2001/XMLSchema#string

Min Chen

http://www.w3.org/2001/XMLSchema#string

Qiu-Xia Mao

http://www.w3.org/2001/XMLSchema#string

Su-Ying Feng

http://www.w3.org/2001/XMLSchema#string

Wei-Xue Jia

http://www.w3.org/2001/XMLSchema#string

Xu Yao

http://www.w3.org/2001/XMLSchema#string

Xue-Yuan Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society

Cytokines in psoriasis.

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management.

TNFalpha blockade in human diseases: an overview of efficacy and safety.

Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians.

Psoriasis causes as much disability as other major medical diseases.

Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.

Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

P304

5591-5594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S87260

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cheng-Rang Li

P577

2015-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26508833

http://www.w3.org/2001/XMLSchema#string

P932

4610804

http://www.w3.org/2001/XMLSchema#string